Metal leachables in therapeutic biologic products: Origin, impact and detection

American Pharmaceutical Review

Volumn 13, Issue 4, 2010, Pages 76-80

  Zhou, Shuxia ^a   Lewis, Lavinia M ^a   Singh, Satish K ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; COBALT; COPPER; DIPICOLINIC ACID; DRUG; EDETIC ACID; IRON; MANGANESE; METAL; PENTETIC ACID; RUBBER; STAINLESS STEEL;

CHELATION; CONTAINER; DRUG CONTAMINATION; DRUG IMPURITY; DRUG MANUFACTURE; DRUG PACKAGING; GOOD MANUFACTURING PRACTICE; IRON AND STEEL INDUSTRY; LEACHING; QUANTITATIVE ANALYSIS; REVIEW;

EID: 77954260116     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. CDER Guidance Document: container closure systems for packaging human drugs and biologics. 1999.
2. FDA, FDA-Regulated products that contain bisphenol-A; request for information. Federal Register, 2008. 73(200): p. 61136-61136.
3. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH). Guideline for industry: impurities in new drug substances, ICH Q3A, Q3B and Q6A.
4. Arbin, A., S. Jacobsson, K. Hanninen, A. Hagman, and J. Ostelius, Studies on contamination of intravenous solutions from PVC-bags with dynamic headspace GC-MS and LC-diode array techniques. Journal of Pharmaceutical Sciences, 1986. 28: p. 211-218. (Pubitemid 16187099)
5. Goydan, R., et al., High-temperature migration of antioxidants from polyolefins. Food Addit Contam, 1990. 7(3): p. 323-37.
6. Kim, K., S.G. Rhee, and E.R. Stadtman, Nonenzymatic cleavage of proteins by reactive oxygen species generated by dithiothreitol and iron. J Biol Chem, 1985. 260(29): p. 15394-7. (Pubitemid 16170066)
7. Reif, O.W., P. Solkner, and J. Rupp, Analysis and evaluation of filter cartridge extractables for validation in pharmaceutical downstream processing. PDA J Pharm Sci Technol, 1996. 50(6): p. 399-410.
8. Jenke, D., A. Odufu, and M. Poss, The effect of solvent polarity on the accumulation of leachables from pharmaceutical product containers. Eur J Pharm Sci, 2006. 27(2-3): p. 133-42. (Pubitemid 41831248)
9. Nicholas, K., Extractables and leachables determination: a systematic approach to select and qualify a container closure system for a pharmaceutical product. American Pharmaceutical Review, 2006. 9(3): p. 21-27.
10. Osterberg, R.E., Potential toxicity of extractables and leachables in drug product. American Pharmaceutical Review, 2005. 8(2): p. 64-67.
11. Taborsky, C.J., E.B. Sheinin, and D.G. Hunt, A critical approach to the evaluation of packaging components and the regulatory and scientific considerations in developing a testing strategy. Am Pharm Rev, 2006. 9: p. 146-150.
12. Allain. L., Q.W., Impact of package leachables on the stability of pharmaceutical products. American Pharmaceutical Review, 2007. May/June.
13. Borchert, S.J., et al., Accelerated extractable studies of borosilicate glass containers. J Parenter Sci Technol, 1989. 43(2): p. 67-79.
14. Markovic, I., Challenges associated with extractables and/or leachables substances in therapeutic biologic protein products. American Pharmaceutical Review, 2006. 9(6): p. 20-27.
15. Waterman, K.C., et al., Stabilization of pharmaceuticals to oxidative degradation. Pharm Dev Technol, 2002. 7(1): p. 1-32.
16. Fliszar, K.A., D. Walker, and L. Allain, Profiling of metal ions leached from pharmaceutical packaging materials. PDA J Pharm Sci Technol, 2006. 60(6): p. 337-42.
17. Sanga, S.V., Review of glass types available for packaging parenteral solutions. J Parenter Drug Assoc, 1979. 33(2): p. 61-7.
18. Bohrer, D., et al., Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container-chemicals during the heating for sterilisation. J Trace Elem Med Biol, 2003. 17(2): p. 107-15.
19. Kocijan, A., I. Milosev, and B. Pihlar, The influence of complexing agent and proteins on the corrosion of stainless steels and their metal components. J Mater Sci Mater Med, 2003. 14(1): p. 69-77. (Pubitemid 36241299)
20. Ibers, J.A. and R.H. Holm, Modeling coordination sites in metallobiomolecules. Science, 1980. 209(4453): p. 223-35.
21. Sarkar, B., Metal protein interactions. Progress in Food and Nutrition Science, 1987. 11: p. 363-400.
22. Passerini, A., et al., Identifying cysteines and histidines in transition-metal-binding sites using support vector machines and neural networks. Proteins, 2006. 65(2): p. 305-16.
23. Li, S., et al., Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry, 1995. 34(17): p. 5762-72.
24. Marx, G. and M. Chevion, Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate. Biochem J, 1986. 236(2): p. 397-400.
25. Uchida, K. and S. Kawakishi, Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem, 1994. 269(4): p. 2405-10.
26. Zhou, S., B. Zhang, E. Sturm, D. Teagarden, C. Schoneich, P. Kolhe, L. Lewis, M. Bilikallahalli, S. Satish, Comparative evaluation of disodium EDTA adn DTPA as iron chelators to prevent metal catalyzed destabilization of a therapeutic monoclonal antibody. Journal of Pharmaceutical Science, 2010. Accepted.
27. Uversky, V.N., J. Li, and A.L. Fink, Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem, 2001. 276(47): p. 44284-96.
28. Stadtman, E.R., Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem, 1993. 62: p. 797-821.
29. Stadtman, E.R. and C.N. Oliver, Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem, 1991. 266(4): p. 2005-8.
30. Cleland, J.L., M.F. Powell, and S.J. Shire, The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst, 1993. 10(4): p. 307-77.
31. Farber, J.M. and R.L. Levine, Sequence of a peptide susceptible to mixed-function oxidation. Probable cation binding site in glutamine synthetase. J Biol Chem, 1986. 261(10): p. 4574-8.
32. Stadtman, E.R., Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med, 1990. 9(4): p. 315-25.
33. Bee, J.S., et al., Precipitation of a monoclonal antibody by soluble tungsten. J Pharm Sci, 2009. 98(9): p. 3290-301.
34. Phan, G., et al., Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic- pharmacodynamic relationships in rats. Pharm Res, 2006. 23(9): p. 2030-5.
35. Nguyen, T.H., A. Craig, and K.N. Raymond, Transferrin: the role of conformational changes in iron removal by chelators. J. Am. Chem. Soc., 1993. 115: p. 6758-64.
36. Zhao, F., et al., Metal-catalyzed oxidation of histidine in human growth hormone. Mechanism, isotope effects, and inhibition by a mild denaturing alcohol. J Biol Chem, 1997. 272(14): p. 9019-29.
37. Chen, B., et al., Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Pharm Res, 2003. 20(12): p. 1952-60.
38. Lam, X.M., J.Y. Yang, and J.L. Cleland, Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci, 1997. 86(11): p. 1250-5.
39. Ahluwalia, H., B. Uhlenkamp, The importance of quality in corrosion-resistant alloys in biopharmaceutical manufacturing. Pharmaceutical Technology, 2008. 32(3): p. 164-177.
40. Tuthill, A.H., R. Brunkow, Stainless steel for bioprocessing: selection, surface preparation, and cleaning. Bioprocess International, 2004. 2(12): p. 46-53.
41. McKee, D.J. and E. Frieden, Binding of transition metal ions by ceruloplasmin (ferroxidase). Biochemistry, 1971. 10(21): p. 3880-3.